Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System

SAN DIEGO--(BUSINESS WIRE)--Apr 10, 2025--

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States. With an overall MARD of 8.0%, 3 Dexcom G7 15 Day builds on the performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia and increase time in range. 4-8

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250410304660/en/

“The approval of Dexcom G7 15 Day marks another major innovation for Dexcom,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “By listening to the needs of our users, we’re proud to offer the longest lasting wearable and most accurate CGM, giving people the knowledge to better control their diabetes with our best-in-class technology. This milestone sets a new standard in CGM and is a testament to our continued leadership in glucose biosensing. We look forward to bringing it to market in the second half of this year, but in the meantime, we encourage our users to upgrade to our current G7 system to gain the benefits of the most connected CGM brand in the world.”

New with Dexcom G7 15 Day

Dexcom G7 features included with Dexcom G7 15 Day

“Dexcom G7 15 Day makes managing diabetes even easier with its extended wear and greater accuracy,” said Satish Garg, MD, from Barbara David Center for Diabetes at the University of Colorado School of Medicine. “Data recently released during the 18th international Advanced Technologies and Treatments for Diabetes conference in Amsterdam supports that G7 15 Day is the most accurate CGM for adults.”

Dexcom is working closely with its insulin pump partners to ensure that Dexcom G7 15 Day will be compatible with automated insulin delivery systems upon launch. Dexcom G7 15 Day is expected to launch in the US in the second half of 2025.

VisitDexcom.com/startto get started with Dexcom G7 today. To learn more about Dexcom G7 15 Day and for additional information about when it will be available in the US, visitDexcom.com/15day.

About Dexcom

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.

Category: IR

* A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. When using the product per package labeling, approximately 26% of sensors may not last for the full 15 days. † Excludes implantable CGM systems. ‡ Compared to a prior generation Dexcom CGM System. § The Dexcom G7 Sensor is water-resistant and may be submerged under eight feet of water for up to 24 hours without failure when properly installed. || Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 33 feet of the Dexcom G7. ¶ Smart device sold separately. To view a list of compatible devices, visit dexcom.com/compatibility. # Automated activity and medication logging available in Dexcom G7 app only. ** Healthcare providers can register for Dexcom Clarity at clarity.dexcom.com/professional/registration. †† An internet connection is required for patients to send their glucose data to Dexcom Clarity via a compatible smart device: dexcom.com/compatibility. Healthcare providers will only be able to view a patient’s glucose data if the patient elects to share it with them through Dexcom Clarity. ‡‡ Separate Dexcom Follow app and internet connection required. Users should always confirm readings on the Dexcom G7 app or receiver before making treatment decisions.

1 Dexcom, Data on File, 2025. 2 Dexcom, Data on File, 2023. 3 Garg SK, et al. Diabetes Technol Ther. 2025. doi: 10.1089/dia.2025.0139. Epub ahead of print. 4 Beck RW, et al. JAMA. 2017;317(4):371-378. 5 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 6 Martens T, et al. JAMA. 2021;325(22):2262-2272. 7 Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 8 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7. 9 Polonsky WH, et al. Diabetes Technol Ther. 2021;23(3):195-202.

Now the longest lasting and most accurate CGM system, Dexcom G7 15 Day gives users the knowledge to better control diabetes.

Dexcom G7 15 Day is now cleared in the US for people age 18 years and above with diabetes.

RALEIGH, N.C. (AP) — The father of NASCAR driver Denny Hamlin died and his mother was critically injured after a weekend fire heavily damaged the North Carolina home where they lived, officials said Monday.

Firefighters arrived Sunday night at a two-story home near Stanley that was mostly engulfed in fire, with flames showing through the attic, the Gaston County Office of Emergency Management and Fire Services said in a news release.

Dennis Hamlin, 75, and Mary Lou Hamlin, 69, were found outside the home, suffering from catastrophic injuries, officials said. Dennis Hamlin later died from his injuries at a hospital, officials said.

Mary Lou Hamlin was taken to Atrium Health Wake Forest Baptist Burn Center in Winston-Salem, where she was being treated Monday, officials said.

The fire caused the structure to collapse. The cause is under investigation.

Stanley is located about 20 miles (32 kilometers) northwest of Charlotte.

The home is owned by a company called Won One Real Estate that lists Denny Hamlin as its manager, according to local property tax records and a business document filing with the North Carolina Secretary of State’s Office.

Representatives for Hamlin had not responded to requests for comment as of Monday evening.

Hamlin is one of the marquee drivers in NASCAR's top circuit, having won 60 NASCAR Cup Series races, including the Daytona 500 three times.

The 45-year-old driver for Joe Gibbs Racing has yet to win a Cup points championship. He fell short of the title during this season's final race in Arizona last month.

Weeks earlier, Hamlin said his father — who nearly went broke with financial sacrifices to try to get his son into NASCAR — was battling a serious illness, and that he didn't have much time left to live.

“I know for a fact this is my last chance for my dad to see it. I don’t want him going and never getting to see the moment,” Hamlin told The Associated Press.

Hamlin also mentioned his dad in emotional testimony this month at the start of a federal antitrust trial against NASCAR brought in part by 23XI Racing, which is owned by Hamlin and Basketball Hall of Famer Michael Jordan. NASCAR, 23XI Racing and another race team reached a settlement during the trial before jurors ever deliberated.

——

Sainz reported from Memphis, Tennessee.

FILE - Denny Hamlin looks on prior to a NASCAR Cup Series auto race at Charlotte Motor Speedway, Sunday, Oct. 5, 2025, in Concord, N.C. (AP Photo/Matt Kelley, File)